This award supports collaborative development of innovative approaches, technologies, or models that enhance the impact of translational research. It aims to accelerate the translation of scientific discoveries into clinical treatments and health interventions by funding eligible institutions with prior CTSA UM1 awards. Applications undergo NIH peer review, and only meritorious proposals will be funded.
Eligibility is limited to recipients who have previously competed successfully for a Clinical and Translational Science Awards (CTSA) UM1 award or subsequent iterations, either as prime recipients or partnering institutions.
